135P The real-world use of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor mutated (EGFRm) advanced (stage IIIb/IIIc/IV) non-small cell lung cancer (NSCLC) patients

Autor:	Antoinette J. Taylor, M. Chau, A. Marchetti, R. Makin, Natasha B. Leighl, Frank Griesinger, D.A. Kahangire, Y.S. Choi, T. Bailey, M. Silvey, Jeffrey P. Gregg, Rina Hui, Neal Navani, T-Y. Chou, J. Subramanian
Rok vydání:	2021
Předmět:	Pulmonary and Respiratory Medicine Oncology biology business.industry Advanced stage medicine Cancer research biology.protein non-small cell lung cancer (NSCLC) Epidermal growth factor receptor medicine.disease business Tyrosine kinase
Zdroj:	Journal of Thoracic Oncology. 16:S770-S771
ISSN:	1556-0864
DOI:	10.1016/s1556-0864(21)01977-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c61cfc8b82ff4e0295af7c7c39d03a79 https://doi.org/10.1016/s1556-0864(21)01977-8 Zobrazit plný text záznamu